These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34027244)

  • 41. Physiologically-Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles.
    Minnema J; Vandebriel RJ; Boer K; Klerx W; De Jong WH; Delmaar CJE
    Small; 2023 May; 19(21):e2207326. PubMed ID: 36828794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations.
    Sachana M; Shafer TJ; Terron A
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Finding synergies for 3Rs - Toxicokinetics and read-across: Report from an EPAA partners' Forum.
    Laroche C; Aggarwal M; Bender H; Benndorf P; Birk B; Crozier J; Dal Negro G; De Gaetano F; Desaintes C; Gardner I; Hubesch B; Irizar A; John D; Kumar V; Lostia A; Manou I; Monshouwer M; Müller BP; Paini A; Reid K; Rowan T; Sachana M; Schutte K; Stirling C; Taalman R; van Aerts L; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2018 Nov; 99():5-21. PubMed ID: 30144470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.
    Alexander-White C; Bury D; Cronin M; Dent M; Hack E; Hewitt NJ; Kenna G; Naciff J; Ouedraogo G; Schepky A; Mahony C; Europe C
    Regul Toxicol Pharmacol; 2022 Mar; 129():105094. PubMed ID: 34990780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine.
    Ning J; Chen L; Strikwold M; Louisse J; Wesseling S; Rietjens IMCM
    Arch Toxicol; 2019 Mar; 93(3):801-818. PubMed ID: 30661089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The OECD expert meeting on ecotoxicology and environmental fate--towards the development of improved OECD guidelines for the testing of nanomaterials.
    Kühnel D; Nickel C
    Sci Total Environ; 2014 Feb; 472():347-53. PubMed ID: 24461369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
    Kimmel CA
    Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. pksensi: An R package to apply global sensitivity analysis in physiologically based kinetic modeling.
    Hsieh NH; Reisfeld B; Chiu WA
    SoftwareX; 2020; 12():. PubMed ID: 33426260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive Performance of Next Generation Physiologically Based Kinetic (PBK) Model Predictions in Rats Based on In Vitro and In Silico Input Data.
    Punt A; Louisse J; Pinckaers N; Fabian E; van Ravenzwaay B
    Toxicol Sci; 2022 Feb; 186(1):18-28. PubMed ID: 34927682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrating in vitro chemical transplacental passage into a generic PBK model: A QIVIVE approach.
    Fragki S; Hoogenveen R; van Oostrom C; Schwillens P; Piersma AH; Zeilmaker MJ
    Toxicology; 2022 Jan; 465():153060. PubMed ID: 34871708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of Physiologically Based Kinetic Modeling-Based Reverse Dosimetry to Predict in Vivo Toxicity from in Vitro Data.
    Louisse J; Beekmann K; Rietjens IM
    Chem Res Toxicol; 2017 Jan; 30(1):114-125. PubMed ID: 27768849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting the in vivo developmental toxicity of benzo[a]pyrene (BaP) in rats by an in vitro-in silico approach.
    Wang D; Rietdijk MH; Kamelia L; Boogaard PJ; Rietjens IMCM
    Arch Toxicol; 2021 Oct; 95(10):3323-3340. PubMed ID: 34432120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A physiologically based kinetic modeling of ethyl tert-butyl ether in humans-An illustrative application of quantitative structure-property relationship and Monte Carlo simulation.
    Watanabe-Matsumoto S; Yoshida K; Meiseki Y; Ishida S; Hirose A; Yamada T
    J Toxicol Sci; 2022; 47(2):77-87. PubMed ID: 35110473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The adverse outcome pathway concept: A basis for developing regulatory decision-making tools.
    Delrue N; Sachana M; Sakuratani Y; Gourmelon A; Leinala E; Diderich R
    Altern Lab Anim; 2016 Oct; 44(5):417-429. PubMed ID: 27805824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promoting the 3Rs to enhance the OECD fish toxicity testing framework.
    Hutchinson TH; Wheeler JR; Gourmelon A; Burden N
    Regul Toxicol Pharmacol; 2016 Apr; 76():231-3. PubMed ID: 26873775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How to facilitate the implementation of 3D models in China by applying good
    Liu Y; Cai Z; Li N; Alépée N
    Front Toxicol; 2023; 5():1080528. PubMed ID: 36969263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.
    Shi M; Bouwmeester H; Rietjens IMCM; Strikwold M
    Arch Toxicol; 2020 Aug; 94(8):2809-2827. PubMed ID: 32367273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine.
    Ning J; Rietjens IMCM; Strikwold M
    Arch Toxicol; 2019 Oct; 93(10):2943-2960. PubMed ID: 31511935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An integrated QSAR-PBK/D modelling approach for predicting detoxification and DNA adduct formation of 18 acyclic food-borne α,β-unsaturated aldehydes.
    Kiwamoto R; Spenkelink A; Rietjens IM; Punt A
    Toxicol Appl Pharmacol; 2015 Jan; 282(1):108-17. PubMed ID: 25448044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.